Transforming growth factor-β1 decreases melanin synthesis via delayed extracellular signal-regulated kinase activation

International Journal of Biochemistry and Cell Biology

Volumn 36, Issue 8, 2004, Pages 1482-1491

  Kim, Dong Seok ^a   Park, Seo Hyoung ^a   Park, Kyoung Chan ^a  

^a Seoul National University   (South Korea)

Author keywords

ERK; extracellular signal regulated kinase; Melanogenesis; microphthalmia associated transcription factor; MITF; nerve growth factor; NGF; TGF 1; transforming growth factor 1; Transforming growth factor 1; TRP; tyrosinase related protein

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; MELANIN; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; MONOPHENOL MONOOXYGENASE; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA1; TYROSINASE RELATED PROTEIN 1; TYROSINASE RELATED PROTEIN 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL IMMORTALIZATION; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; HYPOPIGMENTATION; MELANOCYTE; MELANOGENESIS; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN SYNTHESIS; REDUCTION; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; DNA-BINDING PROTEINS; DOWN-REGULATION; ENZYME ACTIVATION; MAP KINASE SIGNALING SYSTEM; MELANINS; MELANOCYTES; MICE; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MONOPHENOL MONOOXYGENASE; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 2442513449     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2003.10.023     Document Type: Article

References (44)

1. Alblas J., Slager-Davidov R., Steenbergh P.H., Sussenbach J.S., van der Burg B. The role of MAP kinase in TPA-mediated cell cycle arrest of human breast cancer cells. Oncogene. 16:1998;131-139
2. Bentley N.J., Eisen T., Goding C.R. Melanocyte-specific expression of the human tyrosinase promoter: Activation by the microphthalmia gene product and role of the initiator. Molecular Cell Biology. 14:1994;7996-8006
3. Bertolotto C., Busca R., Abbe P., Bille K., Aberdam E., Ortonne J.P., et al. Different cis-acting elements are involved in the regulation of TRP1 and TRP2 promoter activities by cyclic AMP: Pivotal role of M boxes (GTCATGTGCT) and of microphthalmia. Molecular Cell Biology. 18:1998a;694-702
4. Bertolotto C., Abbe P., Hemesath T.J., Bille K., Fisher D.E., Ortonne J.P., et al. Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes. Journal of Cell Biology. 142:1998b;827-835
5. Busca R., Ballotti R. Cyclic AMP a key messenger in the regulation of skin pigmentation. Pigment Cell Research. 13:2000;60-69
6. Busca R., Bertolotto C., Ortonne J.P., Ballotti R. Inhibition of the phosphatidylinositol 3-kinase/p70(S6)-kinase pathway induces B16 melanoma cell differentiation. Journal of Biological Chemistry. 271:1996;31824-31830
7. Cowley S., Paterson H., Kemp P., Marshall C.J. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell. 77:1994;841-852
8. Dooley T.P., Gadwood R.C., Kilgore K., Thomasco L.M. Development of an in vitro primary screen for skin depigmentation and antimelanoma agents. Skin Pharmacology. 7:1994;188-200
9. Englaro W., Bertolotto C., Busca R., Brunet A., Pages G., Ortonne J.P., et al. Inhibition of the mitogen-activated protein kinase pathway triggers B16 melanoma cell differentiation. Journal of Biological Chemistry. 273:1998;9966-9970
10. Gumienny T.L., Padgett R.W. The other side of TGF-beta superfamily signal regulation: Thinking outside the cell. Trends in Endocrinological Metabolism. 13:2002;295-299
11. Halaban R., Cheng E., Zhang Y., Moellmann G., Hanlon D., Michalak M., et al. Aberrant retention of tyrosinase in the endoplasmic reticulum mediates accelerated degradation of the enzyme and contributes to the dedifferentiated phenotype of amelanotic melanoma cells. Proceeding of the National Academy of Sciences of the United States of America. 94:1997;6210-6215
12. Hearing V.J., Jimenez M. Analysis of mammalian pigmentation at the molecular level. Pigment Cell Research. 2:1989;75-85
13. Hearing V.J., Tsukamoto K. Enzymatic control of pigmentation in mammals. FASEB Journal. 5:1991;2902-2909
14. Hemesath T.J., Price E.R., Takemoto C., Badalian T., Fisher D.E. MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes. Nature. 391:1998;298-301
15. Hodgkinson C.A., Moore K.J., Nakayama A., Steingrimsson E., Copeland N.G., Jenkins N.A., et al. Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell. 74:1993;395-404
16. Hughes A.E., Newton V.E., Liu X.Z., Read A.P. A gene for Waardenburg syndrome type 2 maps close to the human homologue of the microphthalmia gene at chromosome 3p12-p14.1. Nature Genetics. 7:1994;509-512
17. Khaled M., Larribere L., Bille K., Aberdam E., Ortonne J.P., Ballotti R., et al. Glycogen synthase kinase 3beta is activated by cAMP and plays an active role in the regulation of melanogenesis. Journal of Biological Chemistry. 277:2002;33690-33697
18. Kim D.S., Kim S.Y., Chung J.H., Kim K.H., Eun H.C., Park K.C. Delayed ERK activation by ceramide reduces melanin synthesis in human melanocytes. Cell Signal. 14:2002;779-785
19. Kim D.S., Hwang E.S., Lee J.E., Kim S.Y., Kwon S.B., Park K.C. Sphingosine-1-phosphate decreases melanin synthesis via sustained ERK activation and subsequent MITF degradation. Journal of Cell Science. 116:2003;1699-1706
20. Kobayashi T., Urabe K., Winder A., Jimenez-Cervantes C., Imokawa G., Brewington T., et al. Tyrosinase related protein 1 (TRP1) functions as a DHICA oxidase in melanin biosynthesis. EMBO Journal. 13:1994;5818-5825
21. Koo H.M., VanBrocklin M., McWilliams M.J., Leppla S.H., Duesbery N.S., Woude G.F. Apoptosis and melanogenesis in human melanoma cells induced by anthrax lethal factor inactivation of mitogen-activated protein kinase kinase. Proceeding of the National Academy of Sciences of the United States of America. 99:2002;3052-3057
22. Kutz S.M., Hordines J., McKeown-Longo P.J., Higgins P.J. TGF-beta1-induced PAI-1 gene expression requires MEK activity and cell-to-substrate adhesion. Journal of Cell Science. 114:2001;3905-3914
23. Lutz M., Knaus P. Integration of the TGF-beta pathway into the cellular signalling network. Cell Signal. 14:2002;977
24. Marshall C.J. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation. Cell. 80:1995;179-185
25. Martinez-Esparza M., Jimenez-Cervantes C., Beermann F., Aparicio P., Lozano J.A., Garcia-Borron J.C. Transforming growth factor-beta1 inhibits basal melanogenesis in B16/F10 mouse melanoma cells by increasing the rate of degradation of tyrosinase and tyrosinase-related protein-1. Journal of Biological Chemistry. 272:1997;3967-3972
26. Martinez-Esparza M., Ferrer C., Castells M.T., Garcia-Borron J.C., Zuasti A. Transforming growth factor beta1 mediates hypopigmentation of B16 mouse melanoma cells by inhibition of melanin formation and melanosome maturation. International Journal of Biochemistry and Cell Biology. 33:2001;971-983
27. Oka M., Nagai H., Ando H., Fukunaga M., Matsumura M., Araki K., et al. Regulation of melanogenesis through phosphatidylinositol 3-kinase-Akt pathway in human G361 melanoma cells. Journal of Investigation Dermatology. 115:2000;699-703
28. Price E.R., Horstmann M.A., Wells A.G., Weilbaecher K.N., Takemoto C.M., Landis M.W., et al. Alpha-melanocyte-stimulating hormone signaling regulates expression of microphthalmia, a gene deficient in Waardenburg syndrome. Journal of Biological Chemistry. 273:1998;33042-33047
29. Prota G. Some new aspects of eumelanin chemistry. Progress in Clinical and Biological Research. 256:1988;101-124
30. Rodriguez-Barbero A., Obreo J., Yuste L., Montero J.C., Rodriguez-Pena A., Pandiella A., et al. Transforming growth factor-beta1 induces collagen synthesis and accumulation via p38 mitogen-activated protein kinase (MAPK) pathway in cultured L(6)E(9) myoblasts. FEBS Letters. 513:2002;282-288
31. Sale E.M., Atkinson P.G., Sale G.J. Requirement of MAP kinase for differentiation of fibroblasts to adipocytes. EMBO Journal. 14:1995;674-684
32. Steingrimsson E., Moore K.J., Lamoreux M.L., Ferre-D'Amare A.R., Burley S.K., Zimring D.C., et al. Molecular basis of mouse microphthalmia (mi) mutations helps explain their developmental and phenotypic consequences. Nature Genetics. 8:1994;256-263
33. Tachibana M. Evidence to suggest that expression of MITF induces melanocyte differentiation and haploinsufficiency of MITF causes Waardenburg syndrome type 2A. Pigment Cell Research. 10:1997;25-33
34. Tachibana M. MITF: A stream flowing for pigment cells. Pigment Cell Research. 13:2000;230-240
35. Tassabehji M., Newton V.E., Read A.P. Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene. Nature Genetics. 8:1994;251-255
36. Tsuboi T., Kondoh H., Hiratsuka J., Mishima Y. Enhanced melanogenesis induced by tyrosinase gene-transfer increases boron-uptake and killing effect of boron neutron capture therapy for amelanotic melanoma. Pigment Cell Research. 11:1998;275-282
37. Tsukamoto K., Ueda M., Hearing V.J. Melanogenesis in murine melanocytes is suppressed by infection with the v-rasHa oncogene. Pigment Cell Research. 2(Suppl.):1992;181-184
38. Wu M., Hemesath T.J., Takemoto C.M., Horstmann M.A., Wells A.G., Price E.R., et al. c-Kit triggers dual phosphorylations. Genes Development. 14:2000;301-312
39. Xu W., Gong L., Haddad M.M., Bischof O., Campisi J., Yeh E.T., et al. Regulation of microphthalmia-associated transcription factor MITF protein levels by association with the ubiquitin-conjugating enzyme hUBC9. Experimental Cell Research. 255:2000;135-143
40. Yasumoto K., Yokoyama K., Takahashi K., Tomita Y., Shibahara S. Functional analysis of microphthalmia-associated transcription factor in pigment cell-specific transcription of the human tyrosinase family genes. Journal of Biological Chemistry. 272:1997;503-509
41. Yavuzer U., Keenan E., Lowings P., Vachtenheim J., Currie G., Goding C.R. The microphthalmia gene product interacts with the retinoblastoma protein in vitro and is a target for deregulation of melanocyte-specific transcription. Oncogene. 10:1995;123-134
42. Yokoyama K., Suzuki H., Yasumoto K., Tomita Y., Shibahara S. Molecular cloning and functional analysis of a cDNA coding for human DOPAchrome tautomerase/tyrosinase-related protein-2. Biochimica Biophysica et Acta. 1217:1994;317-321
43. York R.D., Yao H., Dillon T., Ellig C.L., Eckert S.P., McCleskey E.W., et al. Rap1 mediates sustained MAP kinase activation induced by nerve growth factor. Nature. 392:1998;622-626
44. York R.D., Molliver D.C., Grewal S.S., Stenberg P.E., McCleskey E.W., Stork P.J. Role of phosphoinositide 3-kinase and endocytosis in nerve growth factor-induced extracellular signal-regulated kinase activation via Ras and Rap1. Molecular Cell Biology. 20:2000;8069-8083